VolitionRx Limited announced that Dr. Jason Terrell tendered written notice of his resignation as Chief Medical Officer, effective as of November 18, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.631 USD | +3.44% | -4.39% | -11.99% |
14/05 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
13/05 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.99% | 50.58M | |
-39.86% | 8.15B | |
+7.39% | 3.6B | |
-1.48% | 2.27B | |
-26.02% | 1.9B | |
-20.07% | 1.72B | |
+8.09% | 922M | |
+19.92% | 731M | |
-12.45% | 679M | |
-29.39% | 503M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- Volitionrx Limited Announces Resignation of Dr. Jason Terrell as Chief Medical Officer